Advanced Neuromelanin Sensitive MRI Measures Detect Parkinson's Disease Effects in Catecholamine Nuclei: Discovery and Validation in Separate Cohorts

被引:0
|
作者
Huddleston, Daniel [1 ]
Langley, Jason [2 ]
McMurray, Rebecca [1 ]
De Louis, Fabiola [4 ]
Factor, Stewart [1 ]
Hu, Xiaoping [3 ]
机构
[1] Emory Univ, Sch Med, Neurol, Atlanta, GA USA
[2] Univ Calif Riverside, Brain Imaging Ctr, Riverside, CA 92521 USA
[3] Univ Calif Riverside, Bioengn, Riverside, CA 92521 USA
[4] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P1.076
引用
收藏
页数:2
相关论文
共 30 条
  • [11] Substantia nigra area evaluated by neuromelanin-sensitive MRI as an imaging biomarker of disease progression in Parkinson's disease
    Fabbri, M.
    Reimao, S.
    Carbalho, M.
    Nunes, R.
    Abreu, D.
    Guedes, L.
    Bouca, R.
    Lobo, P.
    Godinho, C.
    Coelho, M.
    Goncalves, N.
    Rosa, M.
    Antonini, A.
    Ferreira, J.
    MOVEMENT DISORDERS, 2017, 32
  • [12] Neuromelanin-sensitive MRI in the differential diagnosis of elderly white matter lesion from Parkinson's disease
    Aiba, Yosuke
    Sakakibara, Ryuji
    Tsuyusaki, Yohei
    Oki, Takeshi
    Ogata, Tsuyoshi
    Tateno, Fuyuki
    Terada, Hitoshi
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2019, 7 (06): : 322 - 325
  • [13] Advanced Analysis of Electrodermal Activity Measures to Detect the Onset of ON State in Parkinson's Disease
    Barrachina-Fernandez, Mercedes
    Valenzuela-Lopez, Laura
    Moreno-Verdu, Marcos
    Sanchez-Cuesta, Francisco Jose
    Gonzalez-Zamorano, Yeray
    Romero, Juan Pablo
    Sanchez-avila, Carmen
    MATHEMATICS, 2023, 11 (23)
  • [14] Parkinson's disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI
    Depierreux, Frederique
    Parmentier, Eric
    Mackels, Laurane
    Baquero, Katherine
    Degueldre, Christian
    Balteau, Evelyne
    Salmon, Eric
    Phillips, Christophe
    Bahri, Mohamed Ali
    Maquet, Pierre
    Garraux, Gaetan
    NPJ PARKINSONS DISEASE, 2021, 7 (01)
  • [15] Parkinson’s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI
    Frédérique Depierreux
    Eric Parmentier
    Laurane Mackels
    Katherine Baquero
    Christian Degueldre
    Evelyne Balteau
    Eric Salmon
    Christophe Phillips
    Mohamed Ali Bahri
    Pierre Maquet
    Gaëtan Garraux
    npj Parkinson's Disease, 7
  • [16] In vivo marker of substantia nigra depigmentation in Parkinson's disease using optimised neuromelanin sensitive MRI at 3Tesla
    Schwarz, S. T.
    Rittman, T.
    Gontu, V.
    Morgan, P. S.
    Bajaj, N.
    Auer, D. P.
    MOVEMENT DISORDERS, 2010, 25 (07) : S371 - S371
  • [17] Early-stage Parkinson's disease: Abnormal nigrosome 1 and 2 revealed by a voxelwise analysis of neuromelanin-sensitive MRI
    Sung, Young Hee
    Noh, Young
    Kim, Eung Yeop
    HUMAN BRAIN MAPPING, 2021, 42 (09) : 2823 - 2832
  • [18] Neuromelanin sensitive MRI of substantia nigra: An imaging biomarker to differentiate essential tremor from tremor-dominant Parkinson's disease
    Jin, L.
    Wang, J.
    Li, Y.
    Huang, Z.
    Ye, F.
    MOVEMENT DISORDERS, 2018, 33 : S562 - S562
  • [19] Neuromelanin-sensitive MRI of the substantia nigra: An imaging biomarker to differentiate essential tremor from tremor-dominant Parkinson's disease
    Wang, Jian
    Huang, Zhen
    Li, Yuanfang
    Ye, Fang
    Wang, Changpeng
    Zhang, Yong
    Cheng, Xiaoqin
    Fei, Guoqiang
    Liu, Kai
    Zeng, Mengsu
    Zhong, Chunjiu
    Jin, Lirong
    PARKINSONISM & RELATED DISORDERS, 2019, 58 : 3 - 8
  • [20] The relationship between neuromelanin-sensitive MRI, [123I] meta-iodobenzylguanidine scintigraphy and cognition, in patients with Parkinson's disease
    Utsunomiya, T.
    Matsuura, K.
    Ii, Y.
    Shindo, A.
    Umino, M.
    Maeda, M.
    Tomimoto, H.
    MOVEMENT DISORDERS, 2020, 35 : S189 - S189